IL18 and pancreatic insulinoma: The reduction of the IL-18 level in the model A group after treatment indicates significant damage in the pancreatic β cells in insulinoma rats treated with HIV-1 protease inhibitor, which is one of the principles in selecting a drug for insulinoma treatment.